NASDAQ-LISTED COMPANY TO LAUNCH HYPE TREASURY
Nasdaq-listed Sonnet BioTherapeutics has agreed to merge with Rorschach I LLC to become Hyperliquid Strategies, creating a public crypto treasury company that will hold 12.6 million HYPE tokens and $305 million in cash for a total value of $888 million. The transaction includes strategic investors Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital, and 683 Capital, addressing institutional demand for exposure to Hyperliquid. Sonnet shares surged 300% in pre-market trading following the announcement, mirroring the market's enthusiasm for HYPE treasury strategies after Lion Group's similar $600 million initiative in June.